MCMedicalCodingSoftware
D03.22

D03.22: Melanoma in situ of left ear and external auricular canal

Billable / specific codeICD-10-CMleft

D03.22 is a billable, specific ICD-10-CM code for melanoma in situ of left ear and external auricular canal. It is valid for submission on a claim.

Check D03.22 with the rest of the claim: free scrubber

Other codes that can never be billed with D03.22

Their own Excludes1 notes name this code, so the conflict is not listed above.

  • D00Carcinoma in situ of oral cavity, esophagus and stomach
  • D01Carcinoma in situ of other and unspecified digestive organs
  • D02Carcinoma in situ of middle ear and respiratory system
  • D04Carcinoma in situ of skin
  • C43Malignant melanoma of skin
  • D09Carcinoma in situ of other and unspecified sites

Risk adjustment

D03.22 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

  • HCC 23 Prostate, Breast, and Other Cancers and Tumors0.186 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

D03.22 is named in 39 Medicare coverage policies: 39 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

  • A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
  • A52479Oral Anticancer Drugs - Policy Article
  • A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
  • A52986Billing and Coding: Biomarkers for Oncology

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under D03.2

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.